Dr. Lowry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
433 W High St
Bryan, OH 43506Phone+1 419-630-2291Fax+1 419-630-2181
Education & Training
University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1991- University of Virginia Medical CenterResidency, Internal Medicine, 1981 - 1984
Yale School of MedicineClass of 1981
Certifications & Licensure
OH State Medical License 1986 - 2026
MI State Medical License 2014 - 2025
NY State Medical License 2010 - 2025
NM State Medical License 2023 - 2024
PA State Medical License 2000 - 2024
MA State Medical License 1992 - 2014
WV State Medical License 1984 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- Join now to see all
Publications & Presentations
PubMed
- 64 citationsAntileukemic Activity of Shepherdin and Molecular Diversity of Hsp90 InhibitorsBoglarka Gyurkocza, Janet Plescia, Christopher M. Raskett, David S. Garlick, Philip A. Lowry
Journal of the National Cancer Institute. 2006-08-02 - 38 citationsEngraftment of normal murine marrow into nonmyeloablated host mice.Peter J. Quesenberry, Hayley S. Ramshaw, R B Crittenden, F. M. Stewart, S S Rao
Blood Cells. 1994-01-01 - 18 citationsSafety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients.Karen K. Ballen, Pamela S. Becker, K Levebvre, R. Emmons, K. Lee
Oncology. 1999-11-01
Grant Support
- Characterization Of Hemopoietic ProgenitorsNational Heart, Lung, And Blood Institute1990
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
